|
PPP1R15B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.740500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.36100000000117E-05 |
| Normal-vs-Stage2 |
1.309600E-01 |
| Normal-vs-Stage3 |
9.249800E-01 |
| Normal-vs-Stage4 |
8.322600E-01 |
| Stage1-vs-Stage2 |
9.461800E-01 |
| Stage1-vs-Stage3 |
9.225700E-04 |
| Stage1-vs-Stage4 |
2.738100E-02 |
| Stage2-vs-Stage3 |
1.514600E-01 |
| Stage2-vs-Stage4 |
2.276200E-01 |
| Stage3-vs-Stage4 |
8.866600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.818000E-03 |
| Normal-vs-AfricanAmerican |
6.079000E-01 |
| Normal-vs-Asian |
5.145200E-01 |
| Caucasian-vs-AfricanAmerican |
2.367200E-01 |
| Caucasian-vs-Asian |
8.813500E-02 |
| AfricanAmerican-vs-Asian |
5.920200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.875800E-01 |
| Normal-vs-Female |
1.50236999999498E-05 |
| Male-vs-Female |
5.79189999999619E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.529600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.250000E-02 |
| Normal-vs-Age(61-80Yrs) |
6.357700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.627990E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.146400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.502700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.003830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.894400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.945200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.167400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.127500E-02 |
| Normal-vs-Grade 2 |
4.42809999999794E-05 |
| Normal-vs-Grade 3 |
1.746990E-01 |
| Normal-vs-Grade 4 |
5.508400E-01 |
| Grade 1-vs-Grade 2 |
1.853170E-01 |
| Grade 1-vs-Grade 3 |
5.585700E-02 |
| Grade 1-vs-Grade 4 |
1.984430E-02 |
| Grade 2-vs-Grade 3 |
3.023800E-02 |
| Grade 2-vs-Grade 4 |
1.962860E-03 |
| Grade 3-vs-Grade 4 |
1.612180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.29550004057677E-09 |
| Normal-vs-ccB subtype |
2.091700E-02 |
| ccA subtype-vs-ccB subtype |
1.65023550380283E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.033570E-02 |
| Normal-vs-N1 |
2.906400E-02 |
| N0-vs-N1 |
6.025800E-04 |
|
|
